Avid Bioservices Inc (CDMO)

[jakedogman1]

"The CA of 27th July only requests an extra BoD member when Bavituximab gets approved."

another worthless promise from mgmt

from IR mid june responding to questions

"Peregrine’s Phase III Sunrise trial was discontinued. We have no data package to submit to the FDA. In order to file an NDA with the FDA we’d have to conduct multiple successful trials."

Stephanie


The questions:

Here are some questions regarding the Stipulation order (from page 8):


(i) Increase of the Board size. Contingent upon, and within three (3) months of, the Food and Drug Administration’s approval of Company’s product “bavituximab” for marketing in the United States, the Board shall increase the number of the Board members from four to five, and appoint an appropriate and suitable independent candidate to serve as that fifth member.

What is the estimated timeline for FDA approval?

Has PPHM submitted an application?

Will a new clinical trial be required before any approval?

If so, has the trial started and what is the estimated timeline?